Mechanical circulatory support for advanced heart failure: Patients and technology in evolution

Circulation

Volumn 125, Issue 10, 2012, Pages 1304-1315

  Stewart, Garrick C ^a   Givertz, Michael M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cardiomyopathy; Heart failure; Ventricular assist device

Indexed keywords

ASSISTED CIRCULATION; CARDIOVASCULAR EQUIPMENT; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; IMPLANTATION; LEFT VENTRICULAR ASSIST DEVICE; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; PULSATILE FLOW; REVIEW; RISK ASSESSMENT;

CARDIOMYOPATHIES; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; PATIENT SELECTION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 84858392714     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.060830     Document Type: Review

References (88)

1. Gibbon JH Jr. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med. 1954;37:171-185.
2. Liotta D, Hall CW, Henly WS, Cooley DA, Crawford ES, Debakey ME. Prolonged assisted circulation during and after cardiac or aortic surgery. prolonged partial left ventricular bypass by means of intracorporeal circulation. Am J Cardiol. 1963;12:399-405.
3. Helman DN, Rose EA. History of mechanical circulatory support. Prog Cardiovasc Dis. 2000;43:1-4. (Pubitemid 30484563)
4. De Bakey ME. Left ventricular bypass pump for cardiac assistance. Clinical experience. Am J Cardiol. 1971;27:3-11.
5. Cooley DA, Liotta D, Hallman GL, Bloodwell RD, Leachman RD, Milam JD. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol. 1969;24:723-730.
6. De Vries WC, Anderson JL, Joyce LD, Anderson FL, Hammond EH, Jarvik RK, Kolff WJ. Clinical use of the total artificial heart. N Engl J Med. 1984;310:273-278. (Pubitemid 14222039)
7. Hunt SA, Haddad F. The changing face of heart transplantation. J Am Coll Cardiol. 2008;52:587-598.
8. Portner PM, Oyer PE, Pennington DG, Baumgartner WA, Griffith BP, Frist WR, Magilligan DJ Jr, Noon GP, Ramasamy N, Miller PJ. Implantable electrical left ventricular assist system: bridge to transplantation and the future. Ann Thorac Surg. 1989;47:142-150. (Pubitemid 19030471)
9. Miller LW. Left ventricular assist devices are underutilized. Circulation. 2011;123:1552-1558.
10. Stehlik J, Edwards LB, Kucheryavaya AY, Aurora P, Christie JD, Kirk R, Dobbels F, Rahmel AO, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report-2010. J Heart Lung Transplant. 2010;29:1089-1103.
11. Kirklin JK, Naftel DC. Mechanical circulatory support: registering a therapy in evolution. Circ Heart Fail. 2008;1:200-205.
12. Stewart GC, Stevenson LW. Keeping left ventricular assist device acceleration on track. Circulation. 2011;123:1559-1568.
13. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Ulisney KL, Baldwin JT, Young JB. Third INTERMACS Annual Report: the evolution of destination therapy in the United States. J Heart Lung Transplant. 2011;30:115-123.
14. Stehlik J, Feldman DS. 2011-2020: decade of the ventricular assist device. Current Opin Cardiol. 2011;26:230-231.
15. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM, III, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241-2251.
16. Ventura PA, Alharethi R, Budge D, Reid BB, Horne BD, Mason NO, Stoker S, Caine WT, Rasmusson B, Doty J, Clayson SE, Kfoury AG. Differential impact on post-transplant outcomes between pulsatile-and continuous-flow left ventricular assist devices. Clin Transplant. 2011;25:E390-E395.
17. Nativi JN, Drakos SG, Kucheryavaya AY, Edwards LB, Selzman CH, Taylor DO, Hertz MI, Kfoury AG, Stehlik J. Changing outcomes in patients bridged to heart transplantation with continuous-versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2011;30:854-861.
18. Patlolla V, Patten RD, Denofrio D, Konstam MA, Krishnamani R. The effect of ventricular assist devices on post-transplant mortality an analysis of the United network for organ sharing thoracic registry. J Am Coll Cardiol. 2009;53:264-271.
19. Fang JC. Rise of the machines-left ventricular assist devices as permanent therapy for advanced heart failure. N Engl J Med. 2009;361:2282-2285.
20. Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, Conte JV, Bogaev RC, MacGillivray TE, Naka Y, Mancini D, Massey HT, Chen L, Klodell CT, Aranda JM, Moazami N, Ewald GA, Farrar DJ, Frazier OH. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009;54:312-321.
21. Starling RC, Naka Y, Boyle AJ, Gonzalez-Stawinski G, John R, Jorde U, Russell SD, Conte JV, Aaronson KD, McGee EC Jr, Cotts WG, De Nofrio D, Pham DT, Farrar DJ, Pagani FD. Results of the post-U. S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol. 2011;57:1890-1898.
22. Slaughter MS, Pagani FD, Rogers JG, Miller LW, Sun B, Russell SD, Starling RC, Chen L, Boyle AJ, Chillcott S, Adamson RM, Blood MS, Camacho MT, Idrissi KA, Petty M, Sobieski M, Wright S, Myers TJ, Farrar DJ. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29:S1-S39.
23. Cowger J, Pagani FD, Haft JW, Romano MA, Aaronson KD, Kolias TJ. The development of aortic insufficiency in LVAD supported patients. Circ Heart Fail. 2010;3:668-674.
24. Wilson SR, Mudge GH Jr, Stewart GC, Givertz MM. Evaluation for a ventricular assist device: selecting the appropriate candidate. Circulation. 2009;119:2225-2232.
25. Strueber M, O'Driscoll G, Jansz P, Khaghani A, Levy WC, Wieselthaler GM. Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol. 2011;57:1375-1382.
26. Westaby S, Banning AP, Saito S, Pigott DW, Jin XY, Catarino PA, Robson D, Moorjani N, Kardos A, Poole-Wilson PA, Jarvik R, Frazier OH. Circulatory support for long-term treatment of heart failure: experience with an intraventricular continuous flow pump. Circulation. 2002;105:2588-2591. (Pubitemid 34596032)
27. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.
28. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, Conte JV, Naka Y, Mancini D, Delgado RM, MacGillivray TE, Farrar DJ, Frazier OH. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885-896. (Pubitemid 47347322)
29. Morshuis M, El-Banayosy A, Arusoglu L, Koerfer R, Hetzer R, Wieselthaler G, Pavie A, Nojiri C. European experience of Dura Heart magnetically levitated centrifugal left ventricular assist system. Eur J Cardiothorac Surg. 2009;35:1020-1027.
30. Aaronson K, Slaughter MS, McGee EC Jr, Cotts WG, Acker MA, Jessup M, Gregoric ID, Loyalka P, Jeevanandam V, Anderson A, Kormos RL, Teuteberg JJ, Pagani FD, Boyce S, Hathaway D, Miller L. Evaluation of the Heart Ware HVAD left ventricular assist system for the treatment of advanced heart failure: results of the ADVANCED Bridge to Transplant Trial. Late Breaking Clinical Trials, American Heart Association Scientific Sessions;. November 13-17, 2010; Chicago, IL.
31. Boyle AJ, Russell SD, Teuteberg JJ, Slaughter MS, Moazami N, Pagani FD, Frazier OH, Heatley G, Farrar DJ, John R. Low thromboembolism and pump thrombosis with the Heart Mate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant. 2009;28:881-887.
32. http://clinicaltrials.gov. Unique identifier: NCT01166347. Accessed October 25, 2011.
33. Zierer A, Melby SJ, Voeller RK, Guthrie TJ, Ewald GA, Shelton K, Pasque MK, Moon MR, Damiano RJ Jr, Moazami N. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support. Ann Thorac Surg. 2007;84:515-520. (Pubitemid 47069197)
34. Holman WL, Pamboukian SV, McGiffin DC, Tallaj JA, Cadeiras M, Kirklin JK. Device related infections: are we making progress? J Card Surg. 2010;25:478-483.
35. Slaughter MS, Myers TJ. Transcutaneous energy transmission for mechanical circulatory support systems: history, current status, and future prospects. J Card Surg. 2010;25:484-489.
36. Letsou GV, Shah N, Gregoric ID, Myers TJ, Delgado R, Frazier OH. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant. 2005;24:105-109. (Pubitemid 40094003)
37. Crow S, John R, Boyle A, Shumway S, Liao K, Colvin-Adams M, Toninato C, Missov E, Pritzker M, Martin C, Garry D, Thomas W, Joyce L. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg. 2009;137:208-215.
38. Uriel N, Pak SW, Jorde UP, Jude B, Susen S, Vincentelli A, Ennezat PV, Cappleman S, Naka Y, Mancini D. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol. 2010;56:1207-1213.
39. Meyer AL, Malehsa D, Bara C, Budde U, Slaughter MS, Haverich A, Strueber M. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail. 2010;3:675-681.
40. Pak SW, Uriel N, Takayama H, Cappleman S, Song R, Colombo PC, Charles S, Mancini D, Gillam L, Naka Y, Jorde UP. Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. J Heart Lung Transplant. 2010;29:1172-1176.
41. Mudd JO, Cuda JD, Halushka M, Soderlund KA, Conte JV, Russell SD. Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device. J Heart Lung Transplant. 2008;27:1269-1274.
42. Atluri P, Acker MA. Pulsatile left ventricular assist devices: what is the role in the modern era? Semin Thorac Cardiovasc Surg. 2010;22:106-108.
43. Saito S, Sakaguchi T, Miyagawa S, Yoshikawa Y, Yamauchi T, Ueno T, Kuratani T, Sawa Y. Biventricular support using implantable continuous-flow ventricular assist devices. J Heart Lung Transplant. 2011;30:475-478.
44. Hetzer R, Krabatsch T, Stepanenko A, Hennig E, Potapov EV. Long-term biventricular support with the heartware implantable continuous flow pump. J Heart Lung Transplant. 2011;29:822-824.
45. Copeland JG, Smith RG, Arabia FA, Nolan PE, Sethi GK, Tsau PH, McClellan D, Slepian MJ. Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med. 2004;351:859-867. (Pubitemid 39099324)
46. Jaroszewski DE, Anderson EM, Pierce CN, Arabia FA. The SynCardia freedom driver: a portable driver for discharge home with the total artificial heart. J Heart Lung Transplant. 2011;30:844-845.
47. Meyns B, Klotz S, Simon A, Droogne W, Rega F, Griffith B, Dowling R, Zucker MJ, Burkhoff D. Proof of concept: hemodynamic response to long-term partial ventricular support with the synergy pocket micro-pump. J Am Coll Cardiol. 2009;54:79-86.
48. Friedman PA, Kushwaha SS, Bruce CJ, Park SJ, Ladewig DJ, Mikell SB, Johnson SB, Suddendorf SH, Danielsen AJ, Asirvatham SJ. Use of the aortoatrial continuity as means of providing left ventricular assist support without entering the ventricle: a feasibility study. J Card Fail. 2011;17:511-518.
49. Mancini D, Lietz K. Selection of cardiac transplantation candidates in 2010. Circulation. 2010;122:173-183.
50. Wilson SR, Givertz MM, Stewart GC, Mudge GH Jr. Ventricular assist devices the challenges of outpatient management. J Am Coll Cardiol. 2009;54:1647-1659.
51. Lietz K, Miller LW. Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U. S. United Network of Organ Sharing data, 1990 to 2005. J Am Coll Cardiol. 2007;50:1282-1290. (Pubitemid 47405140)
52. Torre-Amione G, Southard RE, Loebe MM, Youker KA, Bruckner B, Estep JD, Tierney M, Noon GP. Reversal of secondary pulmonary hypertension by axial and pulsatile mechanical circulatory support. J Heart Lung Transplant. 2010;29:195-200.
53. Nair PK, Kormos RL, Teuteberg JJ, Mathier MA, Bermudez CA, Toyoda Y, Dew MA, Simon MA. Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension. J Heart Lung Transplant. 2010;29:201-208.
54. John R, Liao K, Kamdar F, Eckman P, Boyle A, Colvin-Adams M. Effects on pre-and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices. J Thorac Cardiovasc Surg. 2010;140:447-452.
55. Palardy M, Nohria A, Rivero J, Lakdawala N, Campbell P, Kato M, Griffin LM, Smith CM, Couper GS, Stevenson LW, Givertz MM. Right ventricular dysfunction during intensive pharmacologic unloading persists after mechanical unloading. J Card Fail. 2010;16:218-224.
56. Tedford RJ, Hemnes AR, Russell SD, Wittstein IS, Mahmud M, Zaiman AL, Mathai SC, Thiemann DR, Hassoun PM, Girgis RE, Orens JB, Shah AS, Yuh D, Conte JV, Champion HC. PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail. 2008;1:213-219.
57. Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, Naftel DC, Ulisney K, Desvigne-Nickens P, Kirklin JK. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant. 2009;28:535-541.
58. Holman WL, Kormos RL, Naftel DC, Miller MA, Pagani FD, Blume E, Cleeton T, Koenig SC, Edwards L, Kirklin JK. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant. 2009;28:44-50.
59. Pagani FD, Naftel DC, Aaronson KD, Parides MK, Farrar DJ, Pamboukian SV, Kirklin JK. Changing characteristics of patients receiving mechanically assist circulatory support in INTERMACS. J Heart Lung Transplant. 2010;29:S27. Abstract.
60. Stewart GC, Brooks K, Pratibhu PP, Tsang SW, Semigran MJ, Smith CM, Saniuk C, Camuso JM, Fang JC, Mudge GH, Couper GS, Baughman KL, Stevenson LW. Thresholds of physical activity and life expectancy for patients considering destination ventricular assist devices. J Heart Lung Transplant. 2009;28:863-869.
61. Baldwin JT, Mann DL. NHLBI's program for VAD therapy for moderately advanced heart failure: the REVIVE-IT pilot trial. J Card Fail. 2010;16:855-858.
62. Wieselthaler GM, G OD, Jansz P, Khaghani A, Strueber M. Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial. J Heart Lung Transplant. 2010;29:1218-1225.
63. Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J. 2007;154:260-266. (Pubitemid 47079017)
64. Kittleson M, Hurwitz S, Shah MR, Nohria A, Lewis E, Givertz M, Fang J, Jarcho J, Mudge G, Stevenson LW. Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality. J Am Coll Cardiol. 2003;41:2029-2035. (Pubitemid 36677127)
65. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991;83:778-786.
66. Levy WC, Mozaffarian D, Linker DT, Farrar DJ, Miller LW. Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy? J Heart Lung Transplant. 2009;28:231-236.
67. Gorodeski EZ, Chu EC, Chow CH, Levy WC, Hsich E, Starling RC. Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee. Circ Heart Fail. 2010;3:706-714.
68. Ketchum ES, Moorman AJ, Fishbein DP, Mokadam NA, Verrier ED, Aldea GS, Andrus S, Kenyon KW, Levy WC. Predictive value of the Seattle Heart Failure Model in patients undergoing left ventricular assist device placement. J Heart Lung Transplant. 2010;29:1021-1025.
69. Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD, Edwards BS, Park S, John R, Conte JV, Farrar DJ, Slaughter MS. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol. 2010;55:1826-1834.
70. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007;116:497-505. (Pubitemid 47450258)
71. Cowger J, Sundareswaran KS, Rogers JG, Park S, Pagani FD, Bhat G, Jaski B, Farrar DJ, Slaughter MS. The HeartMate II risk score: predicting survival in candidates for left ventricular assist device support. J Heart Lung Transplant. 2011;30:S31. Abstract.
72. Teuteberg JJ, Rogers JG, Park S, Ewald GA, Tatooles AJ, Lietz K, Miller L, Kormos RL, Sundareswaran KS, Farrar DJ, Slaughter MS. Risk assessment for continuous flow left ventricular assist devices (LVAD): does the destination therapy risk score work? An analysis of over 600 patients. J Am Coll Cardiol. 2011;57:E202. Abstract.
73. Fitzpatrick JR III, Frederick JR, Hsu VM, Kozin ED, O'Hara ML, Howell E, Dougherty D, McCormick RC, Laporte CA, Cohen JE, Southerland KW, Howard JL, Jessup ML, Morris RJ, Acker MA, Woo YJ. Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant. 2008;27:1286-1292.
74. Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol. 2008;51:2163-2172. (Pubitemid 351713685)
75. Drakos SG, Janicki L, Horne BD, Kfoury AG, Reid BB, Clayson S, Horton K, Haddad F, Li DY, Renlund DG, Fisher PW. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol. 2010;105:1030-1035.
76. Loforte A, Montalto A, Ranocchi F, Lilla Della Monica P, Casali G, Lappa A, Contento C, Musumeci F. Levitronix CentriMag thirdgeneration magnetically levitated continuous flow pump as bridge to solution. ASAIO J. 2011;57:247-253.
77. Saeed D, Kidambi T, Shalli S, Lapin B, Malaisrie SC, Lee R, Cotts WG, McGee EC Jr. Tricuspid valve repair with left ventricular assist device implantation: is it warranted? J Heart Lung Transplant. 2011;30:530-535.
78. Krishan K, Nair A, Pinney S, Adams DH, Anyanwu AC. Liberal use of tricuspid-valve annuloplasty during left-ventricular assist device implantation. Eur J Cardiothorac Surg. 2012;41:213-217.
79. Mano A, Fujita K, Uenomachi K, Kazama K, Katabuchi M, Wada K, Terakawa N, Arai K, Hori Y, Hashimoto S, Nakatani T, Kitamura S. Body mass index is a useful predictor of prognosis after left ventricular assist system implantation. J Heart Lung Transplant. 2009;28:428-433.
80. Martin SI, Wellington L, Stevenson KB, Mangino JE, Sai-Sudhakar CB, Firstenberg MS, Blais D, Sun BC. Effect of body mass index and device type on infection in left ventricular assist device support beyond 30 days. Inter Cardiovasc Thorac Surg. 2010;11:20-23.
81. Dhesi P, Simsir SA, Daneshvar D, Rafique A, Phan A, Schwarz ER. Left ventricular assist device as 'bridge to weight loss' prior to transplantation in obese patients with advanced heart failure. Ann Transplant. 2011;16:5-13.
82. Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, Mohacsi P, Augustine S, Aaronson K, Barr M. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant. 2006;25:1024-1042. (Pubitemid 44311532)
83. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Ulisney KL, Baldwin JT, Young JB. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant. 2010;29:1-10.
84. Afilalo J, Eisenberg MJ, Morin JF, Bergman H, Monette J, Noiseux N, Perrault LP, Alexander KP, Langlois Y, Dendukuri N, Chamoun P, Kasparian G, Robichaud S, Gharacholou SM, Boivin JF. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J Am Coll Cardiol. 2010;56:1668-1676.
85. Adamson RM, Stahovich M, Chillcott S, Baradarian S, Chammas J, Jaski B, Hoagland P, Dembitsky W. Clinical strategies and outcomes in advanced heart failure patients older than 70 years of age receiving the heartmate ii left ventricular assist device a community hospital experience. J Am Coll Cardiol. 2011;57:2487-2495.
86. Hauptman PJ, Goodlin SJ, Lopatin M, Costanzo MR, Fonarow GC, Yancy CW. Characteristics of patients hospitalized with acute decompensated heart failure who are referred for hospice care. Arch Int Med. 2007;167:1990-1997. (Pubitemid 47606640)
87. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Miller LW, Deng M, Naka Y, Mancini D. Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005. Circ Heart Fail. 2009;2:3-10.
88. Givertz MM. Ventricular assist devices: important information for patients and families. Circulation. 2011;124:e305-e311.